Healthcare

• Atomo Diagnostics Ltd. concentrates its strategy on integrated diagnostic hardware and oem licensing.

• Alterity Therapeutics Ltd. concentrates its strategy on targeted neurodegeneration pharmacology and biomarker readouts.

• Amplia Therapeutics Ltd. concentrates its strategy on stromal matrix penetration and oncology chemosensitisation.

Singular Health Group (ASX:SHG), an Australian healthcare technology company specialising in medical imaging interoperability and three-dimensional visualisation, is expanding the commercial application of its 3DICOM software platform in the United States.

Argent BioPharma Limited (ASX:RGT), an Australian biopharmaceutical company focused on immune modulation, nanotechnology and pharmaceutical development, outlined a revised strategic direction on 12 October 2026. The strategy integrates commercial products, licensed pharmaceutical assets and early-stage research into inflammatory and age-related biological processes.

Ryman Healthcare (ASX:RYM), a retirement living and aged care operator with operations in New Zealand and Australia, reported stronger resale activity in its second-quarter FY27 trading update released on 12 October 2026.

TrivarX Limited (ASX:TRI), an Australian healthcare technology company developing diagnostic and medical imaging solutions, is progressing its Stabl-Im platform towards first-in-human clinical evaluation.